This Week in the Journal

KIT Inhibition by Imatinib in Severe Asthma This proof-of-principle trial showed that imatinib treatment reduced mast-cell activation and improved airway responsiveness in patients with severe refractory asthma. see (Original Article, N Engl J Med 2017;376:1911-1920) Treating Eosinophilic Granulomatosis with Polyangiitis Among participants with eosinophilic granulomatosis with polyangiitis, 32% had remission at weeks 36 and 48 when treated with mepolizumab, an anti-interleukin-5 monoclonal antibody, as compared with 3% of the participants in the placebo group. see....

Medienart:

Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:376

Enthalten in:

The New England journal of medicine - 376(2017), 20, Seite 1910

Sprache:

Englisch

Links:

search.proquest.com

BKL:

44.60

44.00

Themen:

Application programming interface
Asthma
Clinical medicine
Colorectal cancer
Cytokines
Exercise
Firearms
Health risk assessment
Heart failure
Mastectomy
Mutation
Older people
Patients
Physiology
Scarlet fever
Skin

RVK:

RVK Klassifikation

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC1995099805